We are live on
!
Find out more
CAM
Chou Associates Management Portfolio holdings
AUM
$210M
1-Year Est. Return
15.42%
This Fund
S&P 500
This Quarter
Est. Return
+10.29%
1 Year Est. Return
+15.42%
3 Year Est. Return
+71.66%
5 Year Est. Return
+124.52%
10 Year Est. Return
+681.17%
AUM
$324M
AUM Growth
+$22.4M
(+7.4%)
Cap. Flow
-$2.66M
Cap. Flow
% of AUM
-0.82%
Top 10 Holdings %
Top 10 Hldgs %
77.79%
Holding
27
New
–
Increased
2
Reduced
2
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$8.98M |
| 2 |
Bausch Health
BHC
|
+$8.39M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nokia
NOK
|
+$9M |
| 2 |
Citigroup
C
|
+$6.13M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.96% |
| 2 | Financials | 26.59% |
| 3 | Consumer Discretionary | 7.73% |
| 4 | Technology | 4.03% |
| 5 | Industrials | 2.42% |
Similar funds
ESC
FSA
WI
UAH
UI
PCP
RWRC
GHP
Chou Associates Management's Q2 2017 Portfolio in Review
As of Q2 2017, Chou Associates Management held 27 positions worth $324M, up 7.4% from $301M the previous quarter. Its ten largest holdings account for 78% of the portfolio.
Trading was light in Q2 2017: portfolio turnover was 0%. Chou Associates Management opened no new positions and made no exits, leaving the 27-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- Chou Associates Management added most to Teva Pharmaceuticals in Q2 2017, an estimated $8.98M increase.
- Chou Associates Management's biggest Q2 2017 reduction was Nokia, cutting an estimated $9M.
- Chou Associates Management's ten largest holdings make up 78% of its $324M portfolio in Q2 2017.
- Chou Associates Management opened 0 new positions and closed 0 in Q2 2017.
- Chou Associates Management's portfolio value rose 7.4% quarter-over-quarter to $324M.
Based on Chou Associates Management's 13F filing for Q2 2017, filed 15 Aug 2017.